China Transdermal Patch Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Transdermal Patch Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Transdermal Patch Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Transdermal Patch Overall Market Size
2.1 China Transdermal Patch Market Size: 2021 VS 2027
2.2 China Transdermal Patch Revenue, Prospects & Forecasts: 2016-2027
2.3 China Transdermal Patch Sales: 2016-2027
3 Company Landscape
3.1 Top Transdermal Patch Players in China Market
3.2 Top China Transdermal Patch Companies Ranked by Revenue
3.3 China Transdermal Patch Revenue by Companies
3.4 China Transdermal Patch Sales by Companies
3.5 China Transdermal Patch Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Transdermal Patch Companies in China Market, by Revenue in 2020
3.7 Manufacturers Transdermal Patch Product Type
3.8 Tier 1, Tier 2 and Tier 3 Transdermal Patch Players in China Market
3.8.1 List of Tier 1 Transdermal Patch Companies in China
3.8.2 List of Tier 2 and Tier 3 Transdermal Patch Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Transdermal Patch Market Size Markets, 2021 & 2027
4.1.2 Methyl Salicylate-based Patch
4.1.3 Rivastigmine Transdermal Patch
4.1.4 Fentanyl Transdermal Patch
4.1.5 Lidocaine Patch
4.1.6 Diclofenac Patch
4.1.7 Nicotine Transdermal Patch
4.1.8 Others
4.2 By Type - China Transdermal Patch Revenue & Forecasts
4.2.1 By Type - China Transdermal Patch Revenue, 2016-2021
4.2.2 By Type - China Transdermal Patch Revenue, 2022-2027
4.2.3 By Type - China Transdermal Patch Revenue Market Share, 2016-2027
4.3 By Type - China Transdermal Patch Sales & Forecasts
4.3.1 By Type - China Transdermal Patch Sales, 2016-2021
4.3.2 By Type - China Transdermal Patch Sales, 2022-2027
4.3.3 By Type - China Transdermal Patch Sales Market Share, 2016-2027
4.4 By Type - China Transdermal Patch Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Transdermal Patch Market Size, 2021 & 2027
5.1.2 Rx Channel
5.1.3 OTC Channel
5.2 By Application - China Transdermal Patch Revenue & Forecasts
5.2.1 By Application - China Transdermal Patch Revenue, 2016-2021
5.2.2 By Application - China Transdermal Patch Revenue, 2022-2027
5.2.3 By Application - China Transdermal Patch Revenue Market Share, 2016-2027
5.3 By Application - China Transdermal Patch Sales & Forecasts
5.3.1 By Application - China Transdermal Patch Sales, 2016-2021
5.3.2 By Application - China Transdermal Patch Sales, 2022-2027
5.3.3 By Application - China Transdermal Patch Sales Market Share, 2016-2027
5.4 By Application - China Transdermal Patch Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Hisamitsu Pharmaceutical
6.1.1 Hisamitsu Pharmaceutical Corporation Information
6.1.2 Hisamitsu Pharmaceutical Overview
6.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.1.4 Hisamitsu Pharmaceutical Transdermal Patch Product Description
6.1.5 Hisamitsu Pharmaceutical Recent Developments
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Overview
6.2.3 Johnson & Johnson Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.2.4 Johnson & Johnson Transdermal Patch Product Description
6.2.5 Johnson & Johnson Recent Developments
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Overview
6.3.3 Novartis Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.3.4 Novartis Transdermal Patch Product Description
6.3.5 Novartis Recent Developments
6.4 UCB Pharma
6.4.1 UCB Pharma Corporation Information
6.4.2 UCB Pharma Overview
6.4.3 UCB Pharma Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.4.4 UCB Pharma Transdermal Patch Product Description
6.4.5 UCB Pharma Recent Developments
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Overview
6.5.3 Mylan Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.5.4 Mylan Transdermal Patch Product Description
6.5.5 Mylan Recent Developments
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Corporation Information
6.6.2 Teva Pharmaceutical Overview
6.6.3 Teva Pharmaceutical Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.6.4 Teva Pharmaceutical Transdermal Patch Product Description
6.6.5 Teva Pharmaceutical Recent Developments
6.7 Nitto Denko
6.7.1 Nitto Denko Corporation Information
6.7.2 Nitto Denko Overview
6.7.3 Nitto Denko Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.7.4 Nitto Denko Transdermal Patch Product Description
6.7.5 Nitto Denko Recent Developments
6.8 Grünenthal
6.8.1 Grünenthal Corporation Information
6.8.2 Grünenthal Overview
6.8.3 Grünenthal Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.8.4 Grünenthal Transdermal Patch Product Description
6.8.5 Grünenthal Recent Developments
6.9 IBSA Group
6.9.1 IBSA Group Corporation Information
6.9.2 IBSA Group Overview
6.9.3 IBSA Group Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.9.4 IBSA Group Transdermal Patch Product Description
6.9.5 IBSA Group Recent Developments
6.10 GSK
6.10.1 GSK Corporation Information
6.10.2 GSK Overview
6.10.3 GSK Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.10.4 GSK Transdermal Patch Product Description
6.10.5 GSK Recent Developments
6.11 Luye Pharma Group
6.11.1 Luye Pharma Group Corporation Information
6.11.2 Luye Pharma Group Overview
6.11.3 Luye Pharma Group Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.11.4 Luye Pharma Group Transdermal Patch Product Description
6.11.5 Luye Pharma Group Recent Developments
6.12 Pfizer
6.12.1 Pfizer Corporation Information
6.12.2 Pfizer Overview
6.12.3 Pfizer Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.12.4 Pfizer Transdermal Patch Product Description
6.12.5 Pfizer Recent Developments
6.13 Chattem
6.13.1 Chattem Corporation Information
6.13.2 Chattem Overview
6.13.3 Chattem Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.13.4 Chattem Transdermal Patch Product Description
6.13.5 Chattem Recent Developments
6.14 Dr Reddy's Laboratories
6.14.1 Dr Reddy's Laboratories Corporation Information
6.14.2 Dr Reddy's Laboratories Overview
6.14.3 Dr Reddy's Laboratories Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.14.4 Dr Reddy's Laboratories Transdermal Patch Product Description
6.14.5 Dr Reddy's Laboratories Recent Developments
6.15 Bayer
6.15.1 Bayer Corporation Information
6.15.2 Bayer Overview
6.15.3 Bayer Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.15.4 Bayer Transdermal Patch Product Description
6.15.5 Bayer Recent Developments
6.16 Mundipharma
6.16.1 Mundipharma Corporation Information
6.16.2 Mundipharma Overview
6.16.3 Mundipharma Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.16.4 Mundipharma Transdermal Patch Product Description
6.16.5 Mundipharma Recent Developments
6.17 Endo International
6.17.1 Endo International Corporation Information
6.17.2 Endo International Overview
6.17.3 Endo International Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.17.4 Endo International Transdermal Patch Product Description
6.17.5 Endo International Recent Developments
6.18 Beijing Tide Pharmaceutical
6.18.1 Beijing Tide Pharmaceutical Corporation Information
6.18.2 Beijing Tide Pharmaceutical Overview
6.18.3 Beijing Tide Pharmaceutical Transdermal Patch Sales and Revenue in China Market (2016-2021)
6.18.4 Beijing Tide Pharmaceutical Transdermal Patch Product Description
6.18.5 Beijing Tide Pharmaceutical Recent Developments
7 China Transdermal Patch Production Capacity, Analysis
7.1 China Transdermal Patch Production Capacity, 2016-2027
7.2 Transdermal Patch Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Transdermal Patch Supply Chain Analysis
9.1 Transdermal Patch Industry Value Chain
9.2 Transdermal Patch Upstream Market
9.3 Transdermal Patch Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Transdermal Patch Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Transdermal Patch in China Market
Table 2. Top Transdermal Patch Players in China Market, Ranking by Revenue (2019)
Table 3. China Transdermal Patch Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Transdermal Patch Revenue Share by Companies, 2016-2021
Table 5. China Transdermal Patch Sales by Companies, (M Pcs), 2016-2021
Table 6. China Transdermal Patch Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Transdermal Patch Price (2016-2021) & (USD/Pc)
Table 8. Manufacturers Transdermal Patch Product Type
Table 9. List of Tier 1 Transdermal Patch Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Transdermal Patch Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Methyl Salicylate-based Patch
Table 12. Major Manufacturers of Rivastigmine Transdermal Patch
Table 13. By Type - China Transdermal Patch Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Transdermal Patch Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Transdermal Patch Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Transdermal Patch Sales (M Pcs), 2016-2021
Table 17. By Type - China Transdermal Patch Sales (M Pcs), 2022-2027
Table 18. By Application - China Transdermal Patch Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Transdermal Patch Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Transdermal Patch Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Transdermal Patch Sales (M Pcs), 2016-2021
Table 22. By Application - China Transdermal Patch Sales (M Pcs), 2022-2027
Table 23. Hisamitsu Pharmaceutical Corporation Information
Table 24. Hisamitsu Pharmaceutical Description and Major Businesses
Table 25. Hisamitsu Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 26. Hisamitsu Pharmaceutical Transdermal Patch Product
Table 27. Hisamitsu Pharmaceutical Recent Developments
Table 28. Johnson & Johnson Corporation Information
Table 29. Johnson & Johnson Description and Major Businesses
Table 30. Johnson & Johnson Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 31. Johnson & Johnson Transdermal Patch Product
Table 32. Johnson & Johnson Recent Developments
Table 33. Novartis Corporation Information
Table 34. Novartis Description and Major Businesses
Table 35. Novartis Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 36. Novartis Transdermal Patch Product
Table 37. Novartis Recent Developments
Table 38. UCB Pharma Corporation Information
Table 39. UCB Pharma Description and Major Businesses
Table 40. UCB Pharma Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 41. UCB Pharma Transdermal Patch Product
Table 42. UCB Pharma Recent Developments
Table 43. Mylan Corporation Information
Table 44. Mylan Description and Major Businesses
Table 45. Mylan Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 46. Mylan Transdermal Patch Product
Table 47. Mylan Recent Developments
Table 48. Teva Pharmaceutical Corporation Information
Table 49. Teva Pharmaceutical Description and Major Businesses
Table 50. Teva Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 51. Teva Pharmaceutical Transdermal Patch Product
Table 52. Teva Pharmaceutical Recent Developments
Table 53. Nitto Denko Corporation Information
Table 54. Nitto Denko Description and Major Businesses
Table 55. Nitto Denko Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 56. Nitto Denko Transdermal Patch Product
Table 57. Nitto Denko Recent Developments
Table 58. Grünenthal Corporation Information
Table 59. Grünenthal Description and Major Businesses
Table 60. Grünenthal Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 61. Grünenthal Transdermal Patch Product
Table 62. Grünenthal Recent Developments
Table 63. IBSA Group Corporation Information
Table 64. IBSA Group Description and Major Businesses
Table 65. IBSA Group Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 66. IBSA Group Transdermal Patch Product
Table 67. IBSA Group Recent Developments
Table 68. GSK Corporation Information
Table 69. GSK Description and Major Businesses
Table 70. GSK Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 71. GSK Transdermal Patch Product
Table 72. GSK Recent Developments
Table 73. Luye Pharma Group Corporation Information
Table 74. Luye Pharma Group Description and Major Businesses
Table 75. Luye Pharma Group Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 76. Luye Pharma Group Transdermal Patch Product
Table 77. Luye Pharma Group Recent Developments
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Major Businesses
Table 80. Pfizer Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 81. Pfizer Transdermal Patch Product
Table 82. Pfizer Recent Developments
Table 83. Chattem Corporation Information
Table 84. Chattem Description and Major Businesses
Table 85. Chattem Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 86. Chattem Transdermal Patch Product
Table 87. Chattem Recent Developments
Table 88. Dr Reddy's Laboratories Corporation Information
Table 89. Dr Reddy's Laboratories Description and Major Businesses
Table 90. Dr Reddy's Laboratories Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 91. Dr Reddy's Laboratories Transdermal Patch Product
Table 92. Dr Reddy's Laboratories Recent Developments
Table 93. Bayer Corporation Information
Table 94. Bayer Description and Major Businesses
Table 95. Bayer Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 96. Bayer Transdermal Patch Product
Table 97. Bayer Recent Developments
Table 98. Mundipharma Corporation Information
Table 99. Mundipharma Description and Major Businesses
Table 100. Mundipharma Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 101. Mundipharma Transdermal Patch Product
Table 102. Mundipharma Recent Developments
Table 103. Endo International Corporation Information
Table 104. Endo International Description and Major Businesses
Table 105. Endo International Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 106. Endo International Transdermal Patch Product
Table 107. Endo International Recent Developments
Table 108. Beijing Tide Pharmaceutical Corporation Information
Table 109. Beijing Tide Pharmaceutical Description and Major Businesses
Table 110. Beijing Tide Pharmaceutical Transdermal Patch Sales (M Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pc) (2016-2021)
Table 111. Beijing Tide Pharmaceutical Transdermal Patch Product
Table 112. Beijing Tide Pharmaceutical Recent Developments
Table 113. Transdermal Patch Production Capacity (M Pcs) of Key Manufacturers in China Market, 2019-2021 (M Pcs)
Table 114. China Transdermal Patch Capacity Market Share of Key Manufacturers, 2019-2021
Table 115. Transdermal Patch Market Opportunities & Trends in China Market
Table 116. Transdermal Patch Market Drivers in China Market
Table 117. Transdermal Patch Market Restraints in China Market
Table 118. Transdermal Patch Raw Materials
Table 119. Transdermal Patch Raw Materials Suppliers in China Market
Table 120. Typical Transdermal Patch Downstream
Table 121. Transdermal Patch Downstream Clients in China Market
Table 122. Transdermal Patch Distributors and Sales Agents in China Market
List of FiguresFigure 1. Transdermal Patch Product Picture
Figure 2. Transdermal Patch Segment by Type
Figure 3. Transdermal Patch Segment by Application
Figure 4. China Transdermal Patch Market Overview: 2020
Figure 5. China Transdermal Patch Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Transdermal Patch Revenue, 2016-2027 (US$, Mn)
Figure 7. Transdermal Patch Sales in China Market: 2016-2027 (M Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Transdermal Patch Revenue in 2020
Figure 9. Methyl Salicylate-based Patch Product Picture
Figure 10. Rivastigmine Transdermal Patch Product Picture
Figure 11. Fentanyl Transdermal Patch Product Picture
Figure 12. Lidocaine Patch Product Picture
Figure 13. Diclofenac Patch Product Picture
Figure 14. By Type - China Transdermal Patch Sales Market Share, 2016-2027
Figure 15. By Type - China Transdermal Patch Revenue Market Share, 2016-2027
Figure 16. By Type - China Transdermal Patch Price (USD/Pc), 2016-2027
Figure 17. Rx Channel
Figure 18. OTC Channel
Figure 19. By Application - China Transdermal Patch Sales Market Share, 2016-2027
Figure 20. By Application - China Transdermal Patch Revenue Market Share, 2016-2027
Figure 21. By Application - China Transdermal Patch Price (USD/Pc), 2016-2027
Figure 22. Hisamitsu Pharmaceutical Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Johnson & Johnson Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Novartis Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. UCB Pharma Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Mylan Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Teva Pharmaceutical Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Nitto Denko Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Grünenthal Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. IBSA Group Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. GSK Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Luye Pharma Group Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Pfizer Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Chattem Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Dr Reddy's Laboratories Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 36. Bayer Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 37. Mundipharma Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Endo International Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Beijing Tide Pharmaceutical Transdermal Patch Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. China Transdermal Patch Production Capacity (M Pcs), 2016-2027
Figure 41. Transdermal Patch Industry Value Chain
Figure 42. Marketing Channels